Published in Nature on November 06, 2011
Generation of functional human pancreatic β cells in vitro. Cell (2014) 5.90
Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature (2013) 5.43
Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure. Cell (2016) 3.33
Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell (2013) 2.74
Transcriptional and epigenetic dynamics during specification of human embryonic stem cells. Cell (2013) 2.64
Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron (2013) 2.51
Induced pluripotent stem cells: the new patient? Nat Rev Mol Cell Biol (2012) 2.50
From neural development to cognition: unexpected roles for chromatin. Nat Rev Genet (2013) 2.42
Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature (2012) 2.32
Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell (2013) 2.31
Neurotoxic reactive astrocytes are induced by activated microglia. Nature (2017) 2.29
Pluripotent stem cells in regenerative medicine: challenges and recent progress. Nat Rev Genet (2014) 2.12
Autologous mesenchymal stem cell-derived dopaminergic neurons function in parkinsonian macaques. J Clin Invest (2012) 2.11
Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med (2013) 2.10
Accelerated high-yield generation of limb-innervating motor neurons from human stem cells. J Neurosci (2013) 2.08
Induced neuronal cells: how to make and define a neuron. Cell Stem Cell (2011) 1.77
Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat Biotechnol (2013) 1.62
Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription. Cell (2013) 1.61
3D graphene oxide-encapsulated gold nanoparticles to detect neural stem cell differentiation. Biomaterials (2013) 1.54
Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons. Cell Stem Cell (2016) 1.54
Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease. Cell Stem Cell (2014) 1.52
The promise and perils of stem cell therapeutics. Cell Stem Cell (2012) 1.50
Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease. Science (2014) 1.49
Biomedical Application of Dental Tissue-Derived Induced Pluripotent Stem Cells. Stem Cells Int (2016) 1.42
Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. J Clin Invest (2012) 1.40
Negligible immunogenicity of induced pluripotent stem cells derived from human skin fibroblasts. PLoS One (2014) 1.38
Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits. Nat Biotechnol (2013) 1.38
Opportunities and challenges of pluripotent stem cell neurodegenerative disease models. Nat Neurosci (2013) 1.38
A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation. Proc Natl Acad Sci U S A (2013) 1.38
Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs. Cell Rep (2013) 1.36
Generation of integration-free and region-specific neural progenitors from primate fibroblasts. Cell Rep (2013) 1.36
Modeling hippocampal neurogenesis using human pluripotent stem cells. Stem Cell Reports (2014) 1.35
Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc Natl Acad Sci U S A (2013) 1.32
Human pluripotent stem cells: applications and challenges in neurological diseases. Front Physiol (2012) 1.31
Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Stem Cells (2013) 1.31
Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Reports (2014) 1.29
Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat Biotechnol (2014) 1.28
Specification of midbrain dopamine neurons from primate pluripotent stem cells. Stem Cells (2012) 1.28
Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain. Cell Rep (2013) 1.26
Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell (2013) 1.25
Remote control of induced dopaminergic neurons in parkinsonian rats. J Clin Invest (2014) 1.23
Human pluripotent stem cells: an emerging model in developmental biology. Development (2013) 1.22
Perspectives on whole-organ assembly: moving toward transplantation on demand. J Clin Invest (2012) 1.22
Soft microenvironments promote the early neurogenic differentiation but not self-renewal of human pluripotent stem cells. Integr Biol (Camb) (2012) 1.20
Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model. Nat Biotechnol (2015) 1.20
Current status of pluripotent stem cells: moving the first therapies to the clinic. Nat Rev Drug Discov (2015) 1.18
Wnt5a cooperates with canonical Wnts to generate midbrain dopaminergic neurons in vivo and in stem cells. Proc Natl Acad Sci U S A (2013) 1.12
Physiological characterisation of human iPS-derived dopaminergic neurons. PLoS One (2014) 1.12
DMH1, a highly selective small molecule BMP inhibitor promotes neurogenesis of hiPSCs: comparison of PAX6 and SOX1 expression during neural induction. ACS Chem Neurosci (2012) 1.11
Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nat Protoc (2014) 1.10
Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J Comp Neurol (2014) 1.09
Preconditioning stem cells for in vivo delivery. Biores Open Access (2014) 1.09
iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease. Cell Rep (2014) 1.08
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nat Commun (2014) 1.07
A xenogeneic-free system generating functional human gut organoids from pluripotent stem cells. JCI Insight (2017) 1.07
Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells. Biol Psychiatry (2013) 1.05
Large animal models for stem cell therapy. Stem Cell Res Ther (2013) 1.04
Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease. PLoS One (2012) 1.02
Characterizing human stem cell-derived sensory neurons at the single-cell level reveals their ion channel expression and utility in pain research. Mol Ther (2014) 1.01
Pluripotent stem cell-based cancer therapy: promise and challenges. Sci Transl Med (2012) 0.99
The role of microRNAs in human neural stem cells, neuronal differentiation and subtype specification. Cell Tissue Res (2014) 0.98
Modeling psychiatric disorders for developing effective treatments. Nat Med (2015) 0.98
Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes. Cell Rep (2013) 0.98
α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models. Proc Natl Acad Sci U S A (2016) 0.97
Bringing Neural Cell Therapies to the Clinic: Past and Future Strategies. Mol Ther Methods Clin Dev (2016) 0.97
Efficient specification of interneurons from human pluripotent stem cells by dorsoventral and rostrocaudal modulation. Stem Cells (2014) 0.97
Cell-based therapies for Parkinson disease—past insights and future potential. Nat Rev Neurol (2015) 0.97
Generation of dopaminergic neurons directly from mouse fibroblasts and fibroblast-derived neural progenitors. Cell Res (2012) 0.96
Generation of functional human serotonergic neurons from fibroblasts. Mol Psychiatry (2015) 0.96
Human-induced pluripotent stem cells: potential for neurodegenerative diseases. Hum Mol Genet (2014) 0.96
MicroRNA-based promotion of human neuronal differentiation and subtype specification. PLoS One (2013) 0.95
BMP and TGF-β pathway mediators are critical upstream regulators of Wnt signaling during midbrain dopamine differentiation in human pluripotent stem cells. Dev Biol (2013) 0.95
Small molecules greatly improve conversion of human-induced pluripotent stem cells to the neuronal lineage. Stem Cells Int (2012) 0.95
Generation of serotonin neurons from human pluripotent stem cells. Nat Biotechnol (2015) 0.95
Generating regionalized neuronal cells from pluripotency, a step-by-step protocol. Front Cell Neurosci (2013) 0.95
Moving stem cells to the clinic: potential and limitations for brain repair. Neuron (2015) 0.94
Concise review: chemical approaches for modulating lineage-specific stem cells and progenitors. Stem Cells Transl Med (2013) 0.94
Glycogen synthase kinase 3β and activin/nodal inhibition in human embryonic stem cells induces a pre-neuroepithelial state that is required for specification to a floor plate cell lineage. Stem Cells (2012) 0.93
Stem cell and biomaterials research in dental tissue engineering and regeneration. Dent Clin North Am (2012) 0.93
Pathogenesis-targeted, disease-modifying therapies in Parkinson disease. Neurotherapeutics (2014) 0.92
When norepinephrine becomes a driver of breathing irregularities: how intermittent hypoxia fundamentally alters the modulatory response of the respiratory network. J Neurosci (2014) 0.92
Concise review: Generation of neurons from somatic cells of healthy individuals and neurological patients through induced pluripotency or direct conversion. Stem Cells (2014) 0.91
Differential BMP signaling controls formation and differentiation of multipotent preplacodal ectoderm progenitors from human embryonic stem cells. Dev Biol (2013) 0.91
Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells. J Neurogenet (2014) 0.91
Low immunogenicity of neural progenitor cells differentiated from induced pluripotent stem cells derived from less immunogenic somatic cells. PLoS One (2013) 0.91
Genome wide profiling of dopaminergic neurons derived from human embryonic and induced pluripotent stem cells. Stem Cells Dev (2013) 0.91
Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. Nat Rev Neurosci (2016) 0.90
Ectopic Wnt/beta-catenin signaling induces neurogenesis in the spinal cord and hindbrain floor plate. PLoS One (2012) 0.90
Bioengineered stem cells in neural development and neurodegeneration research. Ageing Res Rev (2013) 0.89
Parkinson's disease and mesenchymal stem cells: potential for cell-based therapy. Parkinsons Dis (2012) 0.89
Functional consequences of 17q21.31/WNT3-WNT9B amplification in hPSCs with respect to neural differentiation. Cell Rep (2015) 0.89
Back to the future: how human induced pluripotent stem cells will transform regenerative medicine. Hum Mol Genet (2013) 0.89
Deterministic HOX patterning in human pluripotent stem cell-derived neuroectoderm. Stem Cell Reports (2015) 0.89
Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys. Cell Transplant (2013) 0.88
Dopaminergic axon guidance: which makes what? Front Cell Neurosci (2012) 0.88
An Lmx1b-miR135a2 regulatory circuit modulates Wnt1/Wnt signaling and determines the size of the midbrain dopaminergic progenitor pool. PLoS Genet (2013) 0.88
Altered WNT Signaling in Human Induced Pluripotent Stem Cell Neural Progenitor Cells Derived from Four Schizophrenia Patients. Biol Psychiatry (2015) 0.87
Cortical interneurons from human pluripotent stem cells: prospects for neurological and psychiatric disease. Front Cell Neurosci (2013) 0.87
Epigenetic obstacles encountered by transcription factors: reprogramming against all odds. Curr Opin Genet Dev (2012) 0.87
A guide to generating and using hiPSC derived NPCs for the study of neurological diseases. J Vis Exp (2015) 0.86
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
Efficient tumour formation by single human melanoma cells. Nature (2008) 16.35
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol (2009) 13.16
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02
Specification of motoneurons from human embryonic stem cells. Nat Biotechnol (2005) 7.74
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A (2008) 7.52
Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A (2004) 7.51
Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med (2006) 7.21
Dopamine neuron agenesis in Nurr1-deficient mice. Science (1997) 5.40
Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev (2008) 5.34
Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes. Mol Cell Biol (1989) 4.47
Dorsal differentiation of neural plate cells induced by BMP-mediated signals from epidermal ectoderm. Cell (1995) 3.64
Stem cells in human neurodegenerative disorders--time for clinical translation? J Clin Invest (2010) 3.62
Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A (2010) 2.85
Floor plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the notochord. Cell (1994) 2.58
The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol (2007) 2.54
Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner. Development (2007) 2.40
Robust pacemaking in substantia nigra dopaminergic neurons. J Neurosci (2009) 2.35
miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells. Cell Stem Cell (2011) 2.33
Differential requirement for the dual functions of β-catenin in embryonic stem cell self-renewal and germ layer formation. Nat Cell Biol (2011) 2.32
Wnt antagonism of Shh facilitates midbrain floor plate neurogenesis. Nat Neurosci (2009) 2.03
Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell (2010) 2.02
Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc Natl Acad Sci U S A (2008) 2.01
Wnt signaling plays an essential role in neuronal specification of the dorsal spinal cord. Genes Dev (2002) 2.01
Nifedipine- and omega-conotoxin-sensitive Ca2+ conductances in guinea-pig substantia nigra pars compacta neurones. J Physiol (1993) 1.90
Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci (1996) 1.61
Therapeutic cloning in individual parkinsonian mice. Nat Med (2008) 1.46
Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft. Eur J Neurosci (2006) 1.32
Development, maturation, and necessity of transcription factors in the mouse suprachiasmatic nucleus. J Neurosci (2011) 1.30
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol (2009) 13.16
A translational profiling approach for the molecular characterization of CNS cell types. Cell (2008) 8.69
Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A (2004) 7.51
Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med (2006) 7.21
Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature (2009) 7.04
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol (2003) 6.21
Glioblastoma stem-like cells give rise to tumour endothelium. Nature (2010) 6.18
Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet (2002) 6.02
Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A (2006) 5.78
Dichotomous dopaminergic control of striatal synaptic plasticity. Science (2008) 5.47
Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev (2008) 5.34
'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature (2007) 5.03
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci (2006) 4.98
Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci U S A (2008) 4.97
Modulation of striatal projection systems by dopamine. Annu Rev Neurosci (2011) 4.84
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol (2002) 4.60
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature (2010) 4.07
Parkinson's disease. Hum Mol Genet (2007) 3.84
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol (2010) 3.84
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol (2002) 3.84
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron (2006) 3.58
Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol (2007) 3.48
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med (2005) 3.46
Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol (2003) 3.43
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol (2008) 3.35
Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med (2009) 3.32
Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci (2009) 3.24
Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol (2002) 3.23
Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells (2007) 3.11
Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med (2005) 3.04
Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines. Neuron (2007) 2.93
Thalamic gating of corticostriatal signaling by cholinergic interneurons. Neuron (2010) 2.92
Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat Neurosci (2010) 2.90
Missing pieces in the Parkinson's disease puzzle. Nat Med (2010) 2.90
Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci U S A (2009) 2.86
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron (2003) 2.80
Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci U S A (2004) 2.77
Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med (2008) 2.74
Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell (2013) 2.74
Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem (2002) 2.68
Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med (2007) 2.61
Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc Natl Acad Sci U S A (2005) 2.58
Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J Neurosci (2004) 2.57
Parthenogenetic stem cells in nonhuman primates. Science (2002) 2.54
Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent. Nat Biotechnol (2010) 2.54
Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell (2013) 2.51
Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol (2009) 2.46
Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol (2010) 2.43
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J Biol Chem (2004) 2.43
Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A (2007) 2.43
Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc Natl Acad Sci U S A (2010) 2.36
Robust pacemaking in substantia nigra dopaminergic neurons. J Neurosci (2009) 2.35
miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells. Cell Stem Cell (2011) 2.33
Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature (2012) 2.32
Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell (2013) 2.31
Dichotomous anatomical properties of adult striatal medium spiny neurons. J Neurosci (2008) 2.29
Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron (2009) 2.26
Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? Neurobiol Dis (2006) 2.23
Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest (2011) 2.23
BAC transgenesis in human embryonic stem cells as a novel tool to define the human neural lineage. Stem Cells (2009) 2.22
Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci (2007) 2.19
Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci U S A (2007) 2.19
Substantia nigra tangles are related to gait impairment in older persons. Ann Neurol (2006) 2.17
Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons. Nat Neurosci (2007) 2.15
Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease. J Neurosci (2008) 2.10
Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat Biotechnol (2012) 2.09
Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease. Ann Neurol (2012) 2.08
Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic Biol Med (2002) 2.08
Derivation of neural crest cells from human pluripotent stem cells. Nat Protoc (2010) 2.05
Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell (2010) 2.02
Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism. PLoS Biol (2004) 2.02
Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. J Neurosci (2002) 2.01
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med (2012) 1.99
Mitochondrial dysfunction and amyotrophic lateral sclerosis. Muscle Nerve (2006) 1.95
MicroRNA-128 governs neuronal excitability and motor behavior in mice. Science (2013) 1.95
Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. PLoS One (2011) 1.93
Therapeutic effects of cystamine in a murine model of Huntington's disease. J Neurosci (2002) 1.92